Especially with three Directors buying in the last few days. Not big volumes but still encouraging. Hopefully next year will be interesting.
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025